Introduction
============

To ensure their survival and persistence in the environment, prokaryotes have developed several defense strategies against invading genetic elements, such as viruses and plasmids. Innate defense mechanisms have been known for years and include restriction modification systems, the alteration of virus receptors on the cell surface, and the secretion of extracellular polymers that prevent virus attachment ([@B1]). Recently, an invader-specific and adaptive defense system was discovered ([@B2]) and named after its typical arrangement of sequence repeats, *i.e.* [c]{.ul}lustered [r]{.ul}egularly [i]{.ul}nterspaced [s]{.ul}hort [p]{.ul}alindromic [r]{.ul}epeats (CRISPR).[^2^](#FN3){ref-type="fn"} The repeats generally occur nearby a group of protein-coding genes named [C]{.ul}RISPR-[as]{.ul}sociated (*cas*) genes ([@B3]). Recently, CRISPR/Cas systems were classified into three major types and several subtypes based on Cas protein sequences ([@B4]).

CRISPR/Cas-mediated immunity is achieved via three phases: adaptation, expression, and interference. In the first stage, a piece of the invader DNA is integrated as new spacer into the 5′-end of the CRISPR locus. Transcription of the CRISPR gene in the expression stage produces a long primary CRISPR RNA (pre-crRNA) that is processed by Cas proteins to generate mature crRNA species. In type III systems, crRNAs are matured with the help of the endogenous RNase III, the Cas9 protein, and a short RNA, which is termed tracrRNA ([@B5]). In the interference phase, the invading nucleic acid is recognized by the respective crRNA (displayed on the surface of Cas proteins) and silenced. For a detailed description of all three steps, see recent reviews ([@B6]--[@B12]).

An essential factor for a successful interference and presumably also for the adaptation stage is the dual recognition of both the protospacer sequence and the nearby [p]{.ul}rotospacer [a]{.ul}djacent [m]{.ul}otif (PAM) which is found only in the natural target. This dual recognition mechanism prevents autoimmunity at the spacer encoded by the chromosomal CRISPR gene ([@B13]). PAM sequences appear to be conserved and show a distinct relationship to the CRISPR repeat sequences, which also show significant conservation, providing a means of classification into CRISPR groups ([@B14], [@B15]). (We are using the following terms here: "CRISPR/Cas type" as classified by Makarova *et al.* ([@B4]) that describes the whole immune system with CRISPR RNAs and the type-specific and subtype-specific Cas proteins and "CRISPR repeat clusters" or "CRISPR group" as defined by Kunin *et al.* ([@B14]) and Mojica *et al.* ([@B15]) that describes the classification of CRISPR groups by their repeats.) PAM sequence requirements and position vary between CRISPR/Cas types; for example, in type I systems, the PAM sequences are found directly upstream of the protospacer, whereas in CRISPR/Cas type II systems, they are located immediately downstream of the protospacer sequence ([@B4]). Up to now, a requirement for PAM sequences by CRISPR/Cas type III systems has not been reported ([@B4]). In the adaptation phase, PAM sequences probably play a crucial role in the selection of protospacers from the invading nucleic acid, but details of the recognition mechanism remain unclear ([@B4], [@B15]).

The importance of PAM sequences in the interference stage of CRISPR/Cas type I systems was recently reported by Semenova *et al.* ([@B16]) using *Escherichia coli* and by Gudbergsdottir *et al.* ([@B17]) using *Sulfolobus islandicus*. Mutation of the PAM sequence resulted in escape from interference in both organisms, showing that a correct PAM sequence is essential for target recognition by the CRISPR/Cas type I system ([@B16], [@B17]). In contrast, the CRISPR/Cas type III system of *Staphylococcus epidermidis* did not require any PAM sequence for interference, suggesting that type III systems in general do not require a PAM sequence ([@B13]).

PAM sequences are easily determined if spacer sequences of CRISPR loci can be matched to known virus or plasmid sequences ([@B15]). However, it is often difficult to find matching sequences to spacers because of the limited sequence information of prokaryotic viruses and plasmids, but the current rapid expansion in whole genome, metagenomic, and metaviromic sequence studies is beginning to provide useful data even in extreme environments, such as hypersaline waters ([@B18]).

Here, we provide the first insights into the function and specific roles of the CRISPR/Cas system of the halophilic euryarchaeon *Haloferax volcanii*. This organism possesses three CRISPR loci, one on the main chromosome and two closely spaced loci on the minichromosome pHV4 ([Fig. 1](#F1){ref-type="fig"}). Between the two pHV4-encoded loci is the only Cas protein gene cassette comprising proteins belonging to CRISPR/Cas type I-B. To identify functional PAM sequences for *Haloferax*, we used a systematic approach using a plasmid-based invader assay.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Strains

*H. volcanii* strains H26 (Δ*pyrE2*) and H119 ([@B19]) were grown aerobically at 45 °C in Hv-YPC (yeast extract, peptone, and casamino acids) medium or in Hv-Ca medium ([@B20]). *E. coli* strains DH5α (Invitrogen) and GM121 ([@B21]) were grown aerobically at 37 °C in 2YT medium ([@B22]).

#### Construction of Plasmids

In the initial screen to identify PAM sequences, di- and trinucleotide combinations were introduced upstream and downstream of spacer1 of CRISPR locus P1 (P1-1) of *H. volcanii* using an overlap extension reaction with *Pfu* polymerase (Fermentas) and different sets of oligonucleotides ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1)). Once the upstream location of the PAM sequence had been established, all PAM candidate sequences were introduced only upstream of the spacer sequence in the subsequent cloning reactions. Reaction products were cloned into the EcoRV-digested vector pTA409 ([@B23]), and the resulting plasmids were sequenced. Plasmids were passaged through *E. coli* GM121 cells (to avoid methylation) and then introduced into *Haloferax* cells using the Polyethylene glycol method ([@B19], [@B24]).

#### Transformation of H. volcanii

Plasmids containing spacer P1-1 and different test PAM sequences were introduced into *H. volcanii* strain H26 (Δ*pyrE2*). Transformants were selected on Hv-Ca plates without uracil. As a positive control, strain H26 was transformed with plasmid pTA409, which is the vector without any inserts. Transformation rates were calculated as the number of colonies obtained by transformation of 1 μg of plasmid DNA (cfu/μg of DNA). Each transformation reaction was conducted at least twice using independent preparations of plasmid. To confirm the identification of a functional PAM sequence, *H. volcanii* cells were transformed at least three times with the plasmid-PAM construct using at least two different plasmid preparations. As observed in the similar study by Gudbergsdottir *et al.* ([@B17]), transformation rates cannot be estimated very accurately; therefore, PAM sequences that led to an at least 100-fold reduction in transformation rates in this plasmid assay are defined as a functional PAM sequence for *H. volcanii*.

#### Isolation of Escape Mutants

After transformation of H26 with pTA409-PAM9 (PAM ACT), 30 clones that survived the plasmid challenge were selected for further analysis. Twenty-six clones (escape mutants 1--26) were from one transformation experiment, and four clones (escape mutants 27--30) were from another transformation experiment.

#### Northern Blot Hybridization

Total RNA was isolated from exponentially growing *H. volcanii* H119 cells as described ([@B25]). To analyze expression of CRISPR RNAs, cells were grown at different temperatures (30, 45, and 48.5 °C) and different salt concentrations (15, 18, and 23%). Cells were harvested at exponential phase (OD~650~ = 0.5) and at stationary phase (OD~650~ = 1.1--1.4), and RNA was extracted. Then 10 μg samples were separated on 8% denaturing gels and subsequently transferred to nylon membranes (Hybond-N+, GE Healthcare). DNA oligonucleotide probes complementary to the repeat sequence (RepeatP1) or to different spacer sequences (Spacer1P1, Spacer1P2, and Spacer1C) were used as probes for hybridization (for primer sequences, see [supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1)).

#### Southern Blot Hybridization

Southern blot analysis was carried out as described in Sambrook and Russel ([@B26]) with the following modifications. Genomic DNA was isolated from *Haloferax* strains as described ([@B19]) and digested using SmaI. Ten micrograms of digested DNA were separated on a 0.7% agarose gel and transferred to a nylon membrane (Hybond-N+, GE Healthcare). The hybridization probe Cas1do was generated by PCR using genomic *Haloferax* DNA as template and DIG-dUTP (dNTP-labeling mixture of DIG DNA Labeling kit, Roche Applied Science) and primers Cas2.1/Cas2.2, yielding an amplimer of 460 bp. A 5′ and 3′ DIG-labeled oligonucleotide (Spacer1.3) was used to detect spacer1 of the CRISPR locus P1 in *H. volcanii* as well as to detect spacer1 encoded on the invader plasmid in plasmid transformants. After hybridization, DIG-labeled probes were detected using the DIG Luminescent Detection kit according to the manufacturer\'s protocol (Roche Applied Science).

#### PCR and Sequence Analysis of H. volcanii Wild-type Strains and Transformants

PCR analysis of CRISPR loci was performed with GoTaq polymerase (Promega) using genomic DNA from *H. volcanii* strains H26 and H119 and primers C1 and C2 for locus C, P1.1 and P1.2 for locus P1 and P2.1, and P2.2 for locus P2. The resulting PCR fragments were cloned and sequenced. PCR for analysis of the *cas* gene cluster was conducted with GoTaq polymerase (Promega) using oligos Cas3/Cas2.1 on genomic DNA from *Haloferax* wild-type strain and transformants as template. This yielded a 4554-bp product from wild-type strain DNA that spanned the *cas* genes *cas3*, *cas4*, and *cas1*. For the investigation of a deletion of spacer1 in the CRISPR locus P1, oligos P1.3 and P1.4 were used, yielding a product of 395 bp in the wild type. The presence of spacer1 in the invader plasmid was investigated by amplifying the plasmid insert with primers US1 and RS1, yielding a product of about 300 bp.

Two escape mutants (25 and 26), which deleted the spacer sequence from the plasmid and did not yield any product upon PCR with primers US1 and RS1, were investigated with a second PCR using primers ColE1 and pyrE2. Here, a PCR product for only one mutant was obtained (escape mutant 25).

PCR products of spacer sequences from the genomic CRISPR locus and PCR products of PAM and spacer sequences from the plasmid were sequenced to detect potential point mutations. From escape mutant strains (escape mutants 3, 4, 17, 24, 27, and 29; [Table 3](#T3){ref-type="table"}) for which no deletions in the *cas* gene cluster or the spacer could be detected, the *cas* gene cluster was amplified using several primers (primers Cas1.1--Cas8.6; [supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1)), and the resulting PCR products were sequenced.

RESULTS
=======

### 

#### The Haloferax CRISPR Genes Are Transcribed and Processed

The *Haloferax* CRISPR/Cas system belongs to the subtype I-B and consists of three CRISPR loci and a *cas* gene cassette that encodes eight Cas proteins ([Fig. 1](#F1){ref-type="fig"}). The repeat sequences of all three CRISPR RNAs are 30 nucleotides long and differ by a single nucleotide ([Fig. 1](#F1){ref-type="fig"}). They belong to the CRISPR group 9 (unfolded archaeal repeats) of the classification described by Kunin *et al.* ([@B14]) and Mojica *et al.* ([@B15]). The leader sequences of all three CRISPR loci are also highly similar, suggesting that the CRISPR loci might be derived from a common ancestral locus.

![**The CRISPR/Cas system of *H. volcanii*.** Two CRISPR genes (*P1* and *P2*) are encoded on minichromosome pHV4 flanking the *cas* gene cluster. The third CRISPR gene is encoded on the chromosome (*C*). The *cas* gene cluster codes for the Cas proteins Cas1, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, and Cas8b. Sequencing of the CRISPR P1 locus of the *Haloferax* strain used in this study (H119) showed that part of this locus was deleted. 23 repeats and 23 spacers are missing in the P1 locus in strain H119. In *Haloferax* strain DS2, the P1 locus contains 40 repeats and 39 spacers. The repeat sequences of the three CRISPR RNAs are identical except for one nucleotide (*bottom right*).](zbc0361220910001){#F1}

PCR amplification of all three CRISPR loci in *Haloferax* strains H119 and H26 confirmed the expected sizes of the C and P2 loci but revealed that the P1 locus was 1.5 kb shorter than expected from the genome sequence of the DS2 strain reported previously ([@B27]). Sequence analysis showed that this locus in the H119 strain was shortened by 23 repeat and 23 spacer sequences in comparison with the DS2 strain ([Fig. 1](#F1){ref-type="fig"}), but no other changes were observed. In summary, the CRISPR loci of *H. volcanii* strain H119 encode 24 spacers (locus C), 16 spacers (locus P1), and 11 spacers (locus P2), respectively.

Expression of the three *Haloferax* CRISPR genes was analyzed by Northern blot hybridization ([Fig. 2](#F2){ref-type="fig"}). All three CRISPR transcripts were detectable and could be seen to be processed into small crRNAs under all conditions monitored, *i.e.* different temperatures, salt concentrations, and growth phases (see "Experimental Procedures") ([Fig. 2](#F2){ref-type="fig"} and data not shown).

![**Expression of CRISPR genes.** RNA from *Haloferax* cultures grown under different conditions was isolated, separated on 8% denaturing polyacrylamide gels, transferred to membranes, and then hybridized to either a P1 repeat probe (*A*) or the first spacer of each CRISPR locus (*B--D*). The P1 repeat probe binds to the repeats of all three CRISPR loci (only one mismatch to the repeat sequences of P2 and C; see [Fig. 1](#F1){ref-type="fig"}). The other probes (spacer1 from P1 (*B*), spacer1 from locus P2 (*C*), and spacer1 from locus C (*D*)) are specific to their respective loci. *Lanes no*, standard conditions; *lanes lowT*, lower temperature (30 °C); *lanes ex*, exponential phase; *lanes st*, stationary phase. The sizes of a DNA marker are shown on the *left* in nucleotides. The crRNA is shown schematically on the *right*.](zbc0361220910002){#F2}

#### Matches to Spacers in the Haloferax Genome and Other Genomes

The 74 spacer sequences of the three CRISPR loci of *H. volcanii* DS2 were compared with sequences in GenBank^TM^ (BLASTN) as well as to environmental sequences at the J. Craig Venter Institute.[^3^](#FN4){ref-type="fn"} Only two significant matches were detected ([Table 1](#T1){ref-type="table"}). Spacer C-14 was highly similar to a sequence about 800 kb distant on the same chromosome within HVO_0372. Although the overall similarity is 76%, so precluding autoimmune targeting by the CRISPR/Cas defense, the alignment shows that the two sequences are identical but for a contiguous 9-nucleotide region located near the 3′-end. HVO_0372 encodes a protein with no known homologues or conserved domains. It occurs within a likely phage/plasmid integrant, bordered at one end by a tRNA gene (HVO_0361) and at the other by an XerC/D-like integrase (HVO_0385) and a nearby partial tRNA copy. Except for one or two cases, such as a phage type integrase (HVO_0379), most of the intervening ORFs are obscure in origin and function. A foreign origin of the chromosomal region from HVO_0361 to HVO_0385 (330--341 kb) is also supported by tetranucleotide frequency analysis (TETRA) ([@B28]). This showed a distinct change in tetramer composition in this region compared with the average for the entire chromosome (data not shown).

###### 

**Haloferax (Hfx.) spacer sequence matches to genomic and metagenomic sequences**

All 74 spacers encoded in the three CRISPR loci of strain DS2 were compared with sequences in GenBank and with a metagenomic data set (GS84) collected by the J. Craig Venter Institute. Here, the two highest scoring matches are shown. In each alignment, the spacer sequence is shown above the matching sequence with dots representing identical bases. Spacer sequences are oriented so that the leader sequence of the CRISPR is upstream (to the left). Potential PAM sequence motifs in the retrieved sequence are shown in bold.

![](zbc036122091t001)

*^a^* Lake Tyrrell is a salt lake in Victoria, Australia. The metagenomic sequences were produced by the J. Craig Venter Institute.

Spacer P1-2 matched closely (88%) to an environmental sequence recovered from a salt lake in Australia (Lake Tyrrell). The alignment shows a perfect match in the 5′-part of the sequence. The matching sequence occurs within an ORF predicted to encode a ParBc domain protein (COG1475), which could function in plasmid partition. As can be seen in the alignments of [Table 1](#T1){ref-type="table"}, the trinucleotide motifs upstream of the protospacer sequences are CAC and TTC ([Table 1](#T1){ref-type="table"}). With only two matches to *Haloferax* spacers, it was not possible to identify potential PAM sequences in the flanking regions. Additional data were required, and this was achieved by a systematic, experimental approach.

#### The Haloferax CRISPR/Cas System Can Recognize Several PAMs

To determine the PAM sequence required for the CRISPR/Cas system in *Haloferax*, we used a plasmid-based invader assay because it has been shown previously that plasmids bearing protospacer sequences with a functional PAM efficiently trigger CRISPR/Cas-mediated defense in cells carrying the corresponding spacer sequence ([@B17], [@B29]). To that end, DNA fragments were generated containing spacer1 of CRISPR locus P1 (spacer P1-1) flanked by dinucleotide combinations ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1): pTA409-PAM4--14 and pTA409-PAM16--17; [Fig. 3](#F3){ref-type="fig"}) and three known trinucleotide PAM sequences ([@B15]) ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1): pTA409-PAM1--3). These fragments were subsequently cloned into the *Haloferax* vector pTA409, yielding a total of 16 plasmids with different candidate PAM motifs upstream as well as downstream of the spacer1 sequence ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M112.377002/DC1): pTA409-PAM1--14 and pTA409-PAM16--17; [Fig. 3](#F3){ref-type="fig"}).

![**A plasmid-based invader assay for the identification of PAM sequences.** *A*, the spacer sequence P1-1 was cloned adjacent to potential PAM sequences into the vector pTA409. For initial screening, the potential PAM sequence was cloned upstream as well as downstream of the spacer sequence. The second screening was done with constructs containing the PAM sequences only upstream of the spacer sequence. Selection for transformants was achieved by growth without uracil, which is only possible with the *pyrE2* selection marker encoded on the vector. Cells can grow if the invader plasmid is retained, such as when it does not trigger a CRISPR/Cas interference response. If a nucleotide combination is active as a PAM, the plasmid will be recognized by the CRISPR/Cas system and degraded, so precluding growth of transformants on selective medium. *B*, transformation of *Haloferax* cells with invader plasmids carrying the correct PAM sequence results in failure to grow for almost all cells (*right* plate, pTA409-PAM9 (ACT)), whereas transformation with the vector (without PAM and P1-1) (*left* plate, pTA409; only a dilution of the transformed cells has been plated) results in a lawn of cells.](zbc0361220910003){#F3}

Plasmid constructs were introduced into *Haloferax* H26 cells, which cannot grow without uracil as the strain lacks the *pyrE2* gene. Transformants were selected by uracil prototrophy conferred by the *pyrE2* gene on the plasmid ([Fig. 3](#F3){ref-type="fig"}). Plasmid elimination via the CRISPR/Cas defense of the host cell should lead to reduced transformation rates. Of the 16 plasmids tested with different sequences adjacent to the spacer1 sequence, two showed very low transformation rates (at least a 100-fold reduction in transformation) compared with the vector pTA409 ([Table 2](#T2){ref-type="table"}). The two plasmids that triggered the defense reaction contained the sequences TTC and CT as PAM sequences. TTC was predicted as a PAM for CRISPR/Cas systems belonging to the CRISPR repeat cluster 3 ([@B15]), whereas to our knowledge, the motif CT has not been reported for any CRISPR/Cas system in the literature.

###### 

**Transformation rates of PAM constructs**

Each construct was tested at least three times, and transformation rates were averaged (see "Experimental Procedures"). The transformation rates of the functional PAM constructs are listed; transformation rates for the non-functional PAM constructs were the same as the transformation rates of the control vector pTA409.

  Plasmid              Transformation rate
  -------------------- ----------------------
                       *cfu*/μ*g DNA*^−*1*^
  pTA409               23,809
  pTA409-PAM3 (TTC)    40
  pTA409-PAM9 (ACT)    5
  pTA409-PAM25 (TAA)   180
  pTA409-PAM26 (TAT)   15
  pTA409-PAM27 (TAG)   5
  pTA409-PAM54 (CAC)   105

#### The PAM Sequence Must Be Located Upstream of the Protospacer

The initial PAM plasmids contained the potential PAM sequences both upstream as well as downstream of the spacer P1-1 sequence in each construct. To determine whether the PAM sequence has to be located 5′ or 3′ to the spacer P1-1 sequence, each of the two identified PAM sequences was cloned either upstream or downstream of spacer P1-1. Challenge of *H. volcanii* cells with these plasmids showed that only constructs in which the PAM sequence was upstream of the spacer P1-1 sequence displayed drastically reduced transformation rates. If the PAM sequences were located downstream of the spacer P1-1 sequence, then transformation rates were equal to those of the control vector pTA409.

#### The H. volcanii PAMs Are Three Nucleotides Long

With one dinucleotide (CT) and one trinucleotide (TTC) being successful in our assay, we wanted to know whether CT indeed functions as a dinucleotide or acts as an ACT trinucleotide (with the first nucleotide A originating from the pTA409 vector). Therefore, 46 different trinucleotide combinations were tested using the same plasmid-based invader assay (this time, motifs were cloned only upstream of spacer1). The previously identified dinucleotide motif CT turned out to be a trinucleotide with A[CT]{.ul} because G[CT]{.ul}, C[CT]{.ul}, and T[CT]{.ul} did not work as PAMs. Furthermore, of the 46 new plasmid constructs, four additional PAM sequences were identified: TAA, TAT, TAG, and CAC. Plasmids with these sequences showed an at least 100-fold drop in transformation rates compared with the vector pTA409 ([Table 2](#T2){ref-type="table"}). Thus, altogether, we could identify six PAM sequences for *Haloferax*: TTC, ACT, TAA, TAT, TAG, and CAC.

#### Cells Survive by Generating Deletions in CRISPR/Cas Genes

Upon transformation of *Haloferax* with the invader plasmid carrying a functional PAM sequence, we observed a few transformants that had survived the plasmid challenge. The integrity of the CRISPR/Cas genes of these "escape mutants" was examined to understand how they managed to survive. Possible escape mechanisms would be (i) the mutation or deletion of Cas protein genes involved in the defense reaction, (ii) mutation or deletion of the spacer P1-1 sequence in the CRISPR locus (P1), and (iii) mutation or deletion of the PAM and/or spacer P1-1 sequence on the invader plasmid. After introduction of the invader plasmid pTA409-PAM9 (with the PAM sequence ACT) into *H. volcanii*, 30 transformants (escape mutants) were selected for further analysis. PCR and Southern blot hybridization showed that 18 of the mutants (60%) had lost the complete *cas* gene cluster ([Fig. 4](#F4){ref-type="fig"}, [Fig. 5](#F5){ref-type="fig"}, and [Table 3](#T3){ref-type="table"}). The region abutting the deletion in these *cas*^−^ mutants was amplified using PCR, and sequence analysis showed that for 12 mutants the deletion was achieved by recombination between repeat 3 of the upstream CRISPR locus (P1) and repeat 3 of the downstream CRISPR locus (P2); in two cases, the recombination had occurred between repeat 4 (P1) and repeat 10 (P2); and in one mutant, it was between repeat 13 (P1) and repeat 9 (P2). One other mutant was generated by recombination in the leader regions of locus P1 and P2, thereby deleting in addition to the *cas* gene cluster the complete P1 locus (including spacer1). The 12 mutants that were generated by recombinations at the same sites most likely were generated independently because after transformation cells do not have time to divide. Another possibility is that the recombination occurred in a *Haloferax* cell prior to transformation.

![**Analysis of CRISPR/Cas escape mutants.** Thirty individual colonies of escape mutants that grew on selective medium after challenge with invader plasmid pTA409-PAM9 (ACT) were analyzed using PCR and Southern blot analyses and grouped into five categories according to the lesions identified. Most surviving colonies (77%) had deletions or mutations of the *cas* gene cluster. Additional ways of escape were the deletion of the spacer P1-1 from the CRISPR locus (10%) or the plasmid (7%). For one escape mutant (3%), the mutations leading to survival could not be identified. One mutant (3%) had a mutation in the PAM sequence, rendering it non-functional. One mutant had a deletion that covered the *cas* gene cluster and CRISPR locus P1 (including spacer1); this mutant is only shown under *cas* gene deletion.](zbc0361220910004){#F4}

![**Analyses of escape mutants for *cas* gene cluster.** *A*, PCR analyses. Twenty-six escape mutants were analyzed by PCR on chromosomal DNA for the presence of the *cas* genes *cas3--cas1*. The *cas* gene locus is shown schematically at the *top*. Primers hybridized as indicated with *arrows* in the *cas3* gene and *cas1* gene. For 10 escape mutants, a full-length PCR product is detected (*lanes 1*, *3*, *4*, *8*, *11*, *14*, *17*, and *24--26*); for the other escape mutants, a shorter PCR product of approximately 1 kb is visible. *Lanes 1--26*, PCR products with chromosomal DNA from escape mutants; *lane M*, DNA size marker (sizes are given at both sides in kilobase pairs); *lane wt*, DNA from H119; *lane* −, control reaction without DNA. *B*, Southern blot of escape mutants. The *cas* gene locus is shown schematically at the *top*. Chromosomal DNA of escape mutants was digested with SmaI, separated on an agarose gel, and blotted. A DIG-labeled probe was used for hybridization as indicated with the *red line* below the *cas1* gene in the scheme. If no deletion in the locus occurred, a 9.2-kb fragment should be detected. The wild-type *cas* gene locus fragment is present in escape mutants 1, 3, 4, 8, 11, 14, 17, 24--27, and 29, confirming the PCR results (see *A* and [Table 3](#T3){ref-type="table"}). The probe used does not pick up any signal for escape mutants 2, 5--7, 9, 10, 12, 13, 15, 16, 18--20, 21--23, 28, and 30. *Lanes 1--30*, DNA from wild-type and escape mutants; *lane wt*, DNA from H119; *lanes M1* and *M2*, DNA size marker (sizes are given at the *left* in kilobase pairs).](zbc0361220910005){#F5}

###### 

**Escape mutants utilize different mechanisms for escaping the CRISPR/Cas-mediated defense**

The mechanisms for evasion of the CRISPR/Cas-mediated defense were analyzed for 30 escape mutants using PCR, sequencing, and Southern blot analyses. If the presence of spacer1 (on the chromosome or the plasmid) or *cas* genes could be shown, this is indicated with "+"; otherwise a "−" is indicated. In column 1, labeled "Escape mutant," the 30 mutants are listed. In column 2, "Spacer1 (PCR)," the results for the PCR analysis of the presence of spacer1 in CRISPR locus P1 are listed. In column 3, "Spacer1 (Southern)," the results for the Southern analysis of the presence of spacer1 in CRISPR locus P1 are listed. Mutants showing signals of wild-type size (2.7 kb) are indicated with (WT). In column 4, "Protospacer1 (Southern)," the results for the Southern analysis of the presence of spacer1 in the plasmid are listed. In column 5, "*cas* genes (PCR)," the results for the PCR analysis of the presence of the *cas* genes are listed. In column 6, "*cas* genes (sequencing)," the *cas* gene clusters of mutants 3, 4, 17, 24, 27, and 29 were sequenced. For mutant 27, no mutations were found in the *cas* gene cluster. In column 7, "*cas* genes (Southern)," the results for the Southern analysis of the presence of the *cas* genes are listed. Major changes determined in the respective deletion mutant are shown in bold.

  Escape mutant                            Spacer1 (PCR)   Spacer1 (Southern)   Protospacer1 (Southern)                     *cas* genes (PCR)   *cas* genes (sequencing)                 *cas* genes (Southern)
  ---------------------------------------- --------------- -------------------- ------------------------------------------- ------------------- ---------------------------------------- ------------------------
  1                                        **−**           **−**                \+                                          \+                  ND[*^a^*](#TF3-1){ref-type="table-fn"}   \+
  2                                        −               \+                   \+                                          **−**               **ND**                                   **−**
  3                                        \+              \+ (WT)              \+                                          \+                  **Mutation in *cas8b***                  \+
  4                                        \+              \+ (WT)              \+                                          \+                  **Mutation in *cas3***                   \+
  5                                        −               \+                   \+                                          **−**               **ND**                                   **−**
  6                                        −               \+                   \+                                          **−**               **ND**                                   **−**
  7                                        −               \+                   \+                                          **−**               **ND**                                   **−**
  8                                        **−**           **−**                \+                                          \+                  ND                                       \+
  9                                        \+              \+                   \+                                          **−**               **ND**                                   **−**
  10                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  11                                       \+              \+ (WT)              **+[*^b^*](#TF3-2){ref-type="table-fn"}**   \+                  ND                                       \+
  12                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  13                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  14                                       **−**           **−**                \+                                          \+                  ND                                       \+
  15                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  16                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  17                                       \+              \+ (WT)              \+                                          \+                  **Mutation in *cas8b***                  \+
  18                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  19                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  20                                       \+              \+                   \+                                          **−**               **ND**                                   **−**
  21                                       \+              \+                   \+                                          **−**               **ND**                                   **−**
  22                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  23                                       −               \+                   \+                                          **−**               **ND**                                   **−**
  24                                       \+              \+ (WT)              \+                                          \+                  **Mutation in *cas3***                   \+
  25                                       \+              \+ (WT)              **−**                                       \+                  ND                                       \+
  26                                       \+              \+ (WT)              **−**                                       \+                  ND                                       \+
  27[*^c^*](#TF3-3){ref-type="table-fn"}   \+              \+                   \+                                          ND                  No mutations                             \+
  28                                       \+              \+                   \+                                          **ND**              **ND**                                   **−**
  29                                       \+              \+                   \+                                          ND                  **Mutation in *cas8b***                  \+
  30                                       −               ND                   \+                                          **ND**              **ND**                                   **−**

*^a^* ND, not determined.

*^b^* Point mutation in PAM sequence.

*^c^* Unknown mutation.

PCR and Southern blot analyses showed that most escape mutants still contained the spacer P1-1 in the genomic CRISPR locus ([Figs. 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, and [7](#F7){ref-type="fig"}). Only four of the 30 mutants were found to have lost the spacer P1-1 sequence in the CRISPR locus P1, one of which was already described above because it had a deletion in the *cas* gene cluster as well as the whole P1 locus. The second mutant had deletions in spacers 1--8, the third had a deletion in spacer1 and spacer2, and the fourth had a deletion in spacers 1--11. In Southern blots, the expected wild-type fragment for the P1 locus of about 2.7 kb was observed for seven mutants, and these also yielded a wild-type sized PCR product for the spacer P1-1 region ([Fig. 6](#F6){ref-type="fig"}). The other mutants showed a larger fragment in the Southern blot with a probe against spacer P1-1. The larger fragment in these isolates is a result of deletion of the *cas* gene cassette, so generating a SmaI fragment of a different size.

![*A*, PCR analysis of escape mutants for the presence of spacer P1-1. Sixteen escape mutants were analyzed by PCR on chromosomal DNA for the presence of spacer P1-1. The CRISPR locus P1 is shown schematically at the *top*. Repeats are shown as *diamonds*, and spacers are shown as *rectangles*. PCR primers bind as indicated by *arrows* in the leader region and spacer4 of the CRISPR locus P1. If P1-1 is present, the expected PCR product would have a size of 395 bp. Three escape mutants generated a full-length PCR product (*lanes 3*, *4*, and *11*), whereas one escape mutant showed a shorter PCR product of approximately 250 bp (*lane 8*). Sequence analysis showed that this mutant had a deletion of two repeats and two spacers (spacer1 and spacer2). For all other mutants, no product was generated, suggesting that there is a longer deletion in this region that prevents binding of one or both PCR primers. *Lanes 1--16*, PCR products with chromosomal DNA from escape mutants; *lane M*, DNA size marker (sizes are given at the *left* of the gel in base pairs); *lane* −, control PCR without addition of template DNA. *B*, Southern blot of escape mutants. The CRISPR locus P1 and flanking regions as well as the invader plasmid carrying the P1-1 and PAM sequences are shown schematically at the *top*. Repeats are shown as *diamonds*, and spacers are shown as *rectangles*. Total DNA (genomic DNA and plasmids (pTA409-PAM9)) was isolated from escape mutants, digested with SmaI, separated on an agarose gel, blotted onto a membrane, and hybridized to a DIG-labeled oligonucleotide complementary to spacer P1-1 (indicated by the *gray line* below spacer1 in the diagram). Using this probe, the P1-1 sequence can be detected on the chromosome as well as on the plasmid pTA409-PAM9. If no deletion in the CRISPR locus occurred, a 2.7-kb fragment should be detected. If the P1-1 spacer was not removed from the plasmid, a 720-bp fragment should be visible. The wild-type CRISPR locus fragment is present in escape mutants 3, 4, and 11, confirming the PCR results (see *A*). The probe did not pick up any signal for escape mutants 1, 8, and 14. In escape mutant 8, at least spacer1 is deleted, but the leader and spacer4 are, according to the PCR product, still present (see *A*). Mutants 2, 5--7, 9, 10, 12, 13, and 15 show a fragment of about 3.5 kb, which is larger than the wild-type band, suggesting a major change in this region. This was confirmed later as all these mutants had the complete *cas* gene cluster and parts of the adjoining CRISPR loci deleted ([Fig. 5](#F5){ref-type="fig"}). All escape mutants analyzed here still contain the P1-1 spacer on the plasmid because in all lanes the 700-bp fragment is visible. *Lanes 1--15*, plasmid and chromosomal DNA from escape mutants; *lane wt*, DNA from H119; *lanes M1* and *M2*, DNA size marker (sizes are given at the *left* in kilobase pairs).](zbc0361220910006){#F6}

The same hybridization showed that except for two escape mutants the spacer P1-1 sequence was still present on the "invader" plasmid ([Figs. 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, and [7](#F7){ref-type="fig"}). The two mutants that had lost the plasmid-borne P1-1 spacer were investigated further with PCR and sequence analysis. For one mutant, we were not able to amplify a PCR product from the plasmid, whereas the other mutant had a deletion covering the multiple cloning site (including the inserted PAM and spacer sequences).

![**Analyses of escape mutants 16--30 for the presence of spacer P1-1.** *A*, PCR analysis. Fourteen escape mutants were analyzed by PCR on chromosomal DNA for the presence of spacer P1-1. The CRISPR locus P1 is shown schematically at the *top*. Repeats are shown as *diamonds*, and spacers are shown as *rectangles*. Primers used are indicated with *arrows* in the leader region and spacer4 of the CRISPR locus P1. If P1-1 is not deleted, the expected PCR product would have a size of 395 bp (*arrow wt*). For nine escape mutants, a full-length PCR product was detected (*lanes 17*, *20*, *21*, and *24--29*). For all other mutants, no product was generated, suggesting that there is a longer deletion in this region that prevents binding of one or both PCR primers. *Lanes 16--30*, PCR products with chromosomal DNA from escape mutants; *lane M*, DNA size marker (sizes are given at the *left* of the gel in base pairs); *lane wt*, control PCR with wild-type DNA. *B*, Southern blot of escape mutants. The CRISPR locus P1 and flanking regions as well as the invader plasmid carrying the P1-1 and PAM sequences are shown schematically at the *top*. Repeats are shown as *diamonds*, and spacers are shown as *rectangles*. Chromosomal DNA and plasmids of escape mutants were digested with SmaI, separated on an agarose gel, and blotted. A DIG-labeled oligonucleotide complementary to spacer P1-1 was used for hybridization as indicated with the *red line* below spacer1 in the scheme. Using this probe, the P1-1 sequence could be detected on the chromosome as well as on the plasmid (if present). If no deletion in the CRISPR locus occurred, a 2.7-kb fragment should be detected (*arrow wt*), and if the P1-1 was not removed from the plasmid, a 720-bp fragment should be visible. The wild-type CRISPR locus fragment of 2.7 kb is present in escape mutants 17, 24--27, and 29, confirming the PCR results (see *A*). A fragment longer than the wild-type fragment is detected in mutants 18--23, 28, and 30. In these mutants, a rearrangement of this locus has occurred as observed later upon analysis of the neighboring *cas* gene cluster ([Figs. 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Some mutants show the presence of spacer1 in the Southern blot (escape mutants 18, 19, 22, 23, and 30) (data not shown) with fragments larger than the expected wild-type fragment of 2.7 kb, but they do not give a signal in the PCR (see *A* and [Table 3](#T3){ref-type="table"}). This is due to the rearrangement in this locus that deletes the complete *cas* gene cluster along with parts of the adjoining CRISPR loci. In these cases, spacer4 from CRISPR locus P1 was also deleted; therefore, the PCR primer cannot bind, and the PCR could not work, but spacer1 is still present. Except for mutants 25 and 26, all escape mutants analyzed here still contain the P1-1 spacer on the plasmid because in these lanes the 700-bp fragment is visible. *Lanes 16--30*, plasmid and chromosomal DNA from escape mutants; *lane wt*, DNA from H119; *lanes M1* and *M2*, DNA size marker (sizes are given at the *left* in kilobase pairs).](zbc0361220910007){#F7}

Finally, seven mutants remained that were shown to have retained spacer P1-1 on both the chromosome and the plasmid as well as a complete *cas* gene cluster. We sequenced the relevant parts of the plasmid (the insert containing the PAM and spacer1 sequence) and the chromosomal spacer1 sequences of these mutants, which revealed that one mutant had a point mutation in the PAM sequence (ACT → GCT), confirming nicely that a correct PAM is essential for interference. For the remaining six mutants, we amplified the *cas* gene cluster and sequenced it. Three of these mutants had mutations in the *cas8b* gene, and two had mutations in the *cas3* gene, rendering them non-functional. One mutant remained for which we could not find any changes in the known CRISPR/Cas genes. We assume that this mutant has mutations in other genes that are required for the immune system but not yet known to be involved in the system.

#### PAM Sequences Are Conserved in Haloarchaea

The CRISPR spacers of *H. volcanii* DS2 showed very few matches to known sequences, probably reflecting the age of isolation of the DS2 strain (*i.e.* 1974). Although genomic and metagenomic data have recently become available from the Dead Sea, it is not likely to include viruses and plasmids that were common in those waters 38 years ago. However, there are many other haloarchaea that carry type I-B CRISPR/Cas systems and for which recent metagenomic data are also available. These would be expected to provide more frequent sequence matches and broader insights into the PAM sequences used by this CRISPR/Cas subtype. One such example is *Haloquadratum walsbyi*, a species that has two strains that have been completely sequenced ([@B30], [@B31]) and for which environmental DNA sequences are available from both of the crystallizer ponds from which these strains were isolated (*i.e.* autochthonous DNA). As shown in [Table 4](#T4){ref-type="table"}, A and B, matches of spacer sequences to autochthonous DNA were more frequent than found for *Haloferax*, and the matching environmental sequences were often within or nearby ORFs related to known or predicted halovirus/phage genes or to chromosomal loci that have been previously found to be common targets of CRISPR/Cas systems (*e.g. cas* genes) ([@B32]). The sequence TTC, which was also identified experimentally in this study, was commonly observed in the matching environmental DNA sequences just upstream of the spacer-contig alignment ([Table 4](#T4){ref-type="table"}).

###### 

**PAM sequences in Haloquadratum**

A, spacers of the three CRISPR loci of *H. walsbyi* C23^T^ were compared with sequences in GenBank and with environmental sequences of the Cheetham saltern crystallizer in Geelong, Australia (from the J. Craig Venter Institute (JCVI) (J. M. Hoffman, D. Fadrosh, M. Lewis, and S. J. Williamson, unpublished data) and Ref. [@B48]). In each alignment, the spacer sequence is shown above the matching sequence with dots representing identical bases. Spacer sequences are oriented so that the leader sequence of the CRISPR is upstream (to the left). Potential PAM sequence motifs in the retrieved sequence are shown in bold. B = C or G or T and M = A or C; these ambiguities are present in the sequences deposited in GenBank. B, spacers of *H.* (*Hqr.*) *walsbyi* HBSQ001 as described in Dyall-Smith *et al.* ([@B31]) are aligned with closely matching sequences found in the C23^T^ strain of *H. walsbyi.* The alignments and potential PAM sequences are presented as described for A. C, repeat sequence of *H. volcanii* CRISPR locus C (top line) aligned to the repeats of CRISPR loci C2 and C3 of *H. walsbyi* (lines 2 and 3). Dots in the locus C3 repeat sequence indicate bases identical to the repeats of CRISPR locus C2.

![](zbc036122091t004)

*^a^* GenBank accession numbers of the form GU735\*\*\* refer to metavirome sequences from the Santa Pola saltern crystallizer pond in Alicante, Spain ([@B18]). Australian metavirome sequences (*e.g.* F7HIURH01BCW6N) are from the Cheetham solar saltern crystallizer in Geelong, Australia ([@B49]) and were produced by the J. Craig Venter Institute.

*^b^* The relationships between CRISPR spacers of the two strains of *Haloquadratum* have been described ([@B31]).

*^c^* This spacer sequence was reconstructed after removal of a known insertion element ([@B31]).

DISCUSSION
==========

### 

#### An Active Defense System

Using an invader plasmid carrying a *Haloferax* CRISPR spacer sequence, it was possible to mimic cell invasion by foreign DNA and trigger a sequence-specific defense. This resulted in dramatically reduced rates of transformation, most likely effected by Cas-mediated cleavage of the plasmid DNA ([@B33]). These results were consistent with the observed CRISPR RNA expression data, and together, they demonstrated that both the expression and defense phases of the CRISPR/Cas system in *Haloferax* were active. As observed here, only a very few *Haloferax* cells grew on medium without uracil when transformed with the invader plasmid carrying a functional PAM sequence. Targeting of the introduced spacer by the CRISPR/Cas system would degrade the plasmid, including the *pyrE2* gene, rendering the cell unable to grow on uracil-free medium. Thus, in our experimental system, interference was most likely directed at the plasmid DNA.

The CRISPR/Cas system of *H. volcanii* has remained remarkably intact given that this organism was isolated over 30 years ago. Although the sequenced strain, DS2, was purchased directly from a culture collection (ATCC 29605) and probably underwent few laboratory passages from submission to sequencing ([@B27]), the H119 strain examined in the present study has had a long history of laboratory culture ([@B19]). It is a Δ*pyrE2* Δ*trpA* Δ*leuB* mutant described in 2004 ([@B19]) and was developed from strain DS70, a derivative of strain DS2 (National Collection of Industrial, Food and Marine Bacteria, 2012) which has been cured of plasmid pHV2 (created in 1996 and described in 2001) ([@B34]). The P1 CRISPR locus of the H119 strain was found to have suffered an internal deletion of 23 repeat/spacer pairs compared with the ancestral DS2 strain. Genomic analyses of *Halobacterium salinarum* revealed similar kinds of changes where passage of the same original strain in two different laboratories accumulated a number of differences, mainly indels ([@B35]).

All three *H. volcanii* CRISPR loci were found to be constitutively transcribed, and the primary transcripts were processed to crRNAs. There is only one *cas* gene cluster in *H. volcanii* on minichromosome pHV4, so processing of the chromosomal CRISPR transcript (from locus C) was presumably facilitated in *trans* by the pHV4-encoded Cas proteins. Plasmid carriage of the main functional CRISPR/Cas system in *Haloferax* is consistent with other studies showing that these defense systems are often found on mobile genetic elements, suggesting frequent lateral transfer ([@B6], [@B36], [@B37]). The constitutive nature of CRISPR RNA expression in *Haloferax* differs from the situation in *E. coli* where expression is usually repressed by a histone-like nucleoid structuring protein, H-NS ([@B38]).

#### Six Different PAM Sequences Can Trigger the Defense Reaction against DNA

To identify functional PAM sequences in *Haloferax*, the invader plasmid system was used to systematically test (proto)spacer adjacent sequence motifs. Six PAM sequences were identified that when present upstream of the spacer sequence activated the CRISPR/Cas response: ACT, TAA, TAT, TAG, TTC, and CAC. This is the highest number of PAMs for a single CRISPR repeat group identified so far. Two of these PAM sequences (TTC and CAC) were also found upstream of the protospacer sequence by our *in silico* analysis. TTC as an upstream PAM sequence was also identified in *Streptococcus mutans* ([@B39]) and in *Xanthomonas* and other organisms belonging to the CRISPR repeat cluster 3 ([@B15]). In *E. coli* (CRISPR/Cas subtype I-E), AWG was identified as an upstream PAM ([@B15], [@B16]). The only other archaeal PAM sequences identified so far, CC and CT, are from the CRISPR/Cas type I system in *Sulfolobus* and are also located upstream of the protospacer ([@B17], [@B40]).

Our system investigates PAM requirements during the defense reaction. The ability of multiple sequence motifs to activate this response indicates that the system is quite flexible, allowing protection from a number of sequence variants within the natural population of foreign DNA elements. This would make sense considering that viruses mutate to escape the CRISPR/Cas system, and tolerating more PAM sequences would counteract mutations made by the virus in that motif. However, the data collected with the *in silico* analysis of *Haloquadratum* regarding protospacer selection for inclusion into CRISPR loci indicate that the adaptation step is more restrictive. It appears that in *Haloquadratum* there is a strong bias toward using protospacers containing only a limited repertoire of PAM sequences with the most common being TTC. Because *H. volcanii* and *H. walsbyi* belong to the same CRISPR system (type I-B) and have very similar repeat sequences, they might have similar PAM requirements. Thus, taking the *in silico* data for *Haloquadratum* and the experimental data for *Haloferax* together, the PAM sequence requirements for interference and for adaptation appear to differ, and relaxed PAM sequence requirements for interference may be advantageous because they hamper invader escape by simple mutations without compromising autoimmunity protection.

Recognition of several different PAM sequences on invading plasmids was also observed in *Streptococcus thermophilus* ([@B41]). Here, the authors discussed that the selective pressure for plasmids compared with bacteriophages is lower, allowing a more degenerate PAM for plasmids than for bacteriophages ([@B41]).

In *Staphylococcus epidermis*, the requirement for the sequence upstream of the protospacer is that it must differ from the repeat sequence, which is upstream of the spacer in the CRISPR locus (*i.e.* the last eight nucleotides of the repeat sequence) ([@B13]). This is an even more relaxed sequence requirement for interference.

The general properties of the CRISPR/Cas system in *H. volcanii* fit well with those of other type I systems, which typically have short (2--5-nucleotide) PAM sequences located upstream of the protospacer sequence and target DNA. Furthermore, results presented clearly show that a "correct" PAM sequence is essential for a successful defense reaction as has been shown for *Sulfolobus* and *E. coli* ([@B16], [@B17]).

#### Conservation of CRISPR/Cas Types in Haloarchaea

Comparison of the *Haloferax* CRISPR system with the haloarchaeal organism *H. walsbyi* showed that both contain a CRISPR/Cas system of type I-B and that the repeat sequences are very similar to each other ([Table 4](#T4){ref-type="table"}C). *In silico* analysis of the *Haloquadratum* spacers with genome databases and metavirome data revealed several matches, allowing the identification of the PAM sequence TTC, which is identical to one of the six PAM sequences found experimentally for *Haloferax* in this study. This conservation confirms earlier observations that PAM sequences are connected to the CRISPR/Cas type and to the CRISPR repeat cluster ([@B42]).

#### Escape through Deletion of the cas Gene Cluster

The plasmid-based invader assay used in this study to mimic foreign DNA differs from a natural invasion (*e.g.* by a virus) in that successful degradation of the plasmid leads not to survival but to the inability to grow on the selective medium used to detect plasmid uptake. However, the clear difference observed in transformation rates of invader plasmid constructs that differed by only 1--3 nucleotides was persuasive evidence of the important role of the PAM sequence in target recognition. Another useful feature of the experimental design was the ability to recover stable transformants that had taken up an invader plasmid carrying a functional PAM. As expected, the majority of these were mutants that had survived (or escaped selection) because of lesions in their CRISPR/Cas system, including many that had lost the entire *cas* gene cluster ([Fig. 4](#F4){ref-type="fig"}). In almost all cases, deletion of the *cas* genes was achieved by recombination between repeats of the upstream and downstream CRISPR loci. Here, more than 60% of the mutants were generated by recombination at the same site. Five mutants had mutations in the *cas3* or *cas8b* gene, which rendered them non-functional. Several escape mutants succeeded in deleting the P1-1 spacer on pHV4; one even deleted the entire P1 CRISPR locus. Removal of spacer sequences by recombination between repeats seems to be a common reaction because internal deletions in CRISPR loci have been observed in several instances ([@B43]--[@B45]), including the *Haloferax* strain used in this study. Such events may help regulate CRISPR length or allow survival upon successful invasion ([@B2], [@B17], [@B40], [@B46], [@B47]). In addition, these deletions are reminiscent of repeat-associated deletions that have been detected upon comparison of *Haloquadratum* strains ([@B31]).

Two mutants removed the protospacer from the invader plasmid. Interestingly, one mutant survived because of a point mutation in the PAM sequence. One mutant did not mutate or delete the PAM sequence or the spacer sequences (neither in the plasmid nor on the chromosome) nor did it delete or mutate the *cas* genes. This mutant may carry a deletion or mutation in another gene important for the defense reaction.

In contrast to the clear preference to survive by deletion of the *cas* gene cluster observed in this study, a previous study in *Sulfolobus* showed that in this organism escape mutants used a variety of deletions to escape death by the immune system. A wide range of deletion sizes was observed with very few being identical ([@B17]). This difference might be because we used the first spacer of the CRISPR locus in our invader plasmid, leaving only the first repeat or the leader sequence for recombination. In addition, in *Haloferax*, the *cas* gene cluster is flanked by CRISPR genes encoded in the same orientation, allowing deletion of the *cas* gene cluster by recombination between repeats from the flanking CRISPR gene clusters.
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